Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVGROTCMKTS:HCYTDOTCMKTS:RSLSDOTCMKTS:UAHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$2.07$1.57M1.291.28 million shsN/AHCYTDH-CYTE$2.02-49.5%$2.02$2.02▼$77.00$521K1.12103 shs400 shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsUAHCUnited American Healthcare$0.01-1.4%$0.01$0.01▼$0.11$1.59M-1.551,019 shs6,098 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%0.00%-75.82%HCYTDH-CYTE0.00%0.00%0.00%0.00%0.00%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%UAHCUnited American Healthcare0.00%-2.16%-3.55%+3.82%-43.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVGRAvingerN/AN/AN/AN/AN/AN/AN/AN/AHCYTDH-CYTEN/AN/AN/AN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVGRAvinger 0.00N/AN/AN/AHCYTDH-CYTE 0.00N/AN/AN/ARSLSDReShape Lifesciences 0.00N/AN/AN/AUAHCUnited American Healthcare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVGRAvinger$7.65M0.21N/AN/A($4.53) per share-0.10HCYTDH-CYTE$1.61M0.32N/AN/A($31.45) per share-0.06RSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVGRAvinger-$18.32M-$11.06N/AN/AN/A-261.06%-5,527.11%-123.25%8/6/2025 (Estimated)HCYTDH-CYTE-$4.80MN/A0.00∞N/A-450.40%N/A-777.68%N/ARSLSDReShape Lifesciences-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/AUAHCUnited American Healthcare$240KN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVGRAvingerN/AN/AN/AN/AN/AHCYTDH-CYTEN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AUAHCUnited American Healthcare$0.08588.24%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVGRAvingerN/A1.210.81HCYTDH-CYTEN/A0.120.12RSLSDReShape Lifesciences0.051.171.07UAHCUnited American HealthcareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVGRAvinger18.30%HCYTDH-CYTEN/ARSLSDReShape LifesciencesN/AUAHCUnited American HealthcareN/AInsider OwnershipCompanyInsider OwnershipAVGRAvinger42.80%HCYTDH-CYTE5.24%RSLSDReShape LifesciencesN/AUAHCUnited American Healthcare14.31%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVGRAvinger703.31 million1.89 millionNot OptionableHCYTDH-CYTE8258,000244,000Not OptionableRSLSDReShape Lifesciences50354,000N/ANot OptionableUAHCUnited American Healthcare31117.06 million100.31 millionNot OptionableHCYTD, RSLSD, UAHC, and AVGR HeadlinesRecent News About These CompaniesUnited American Healthcare CorpShsMay 6, 2025 | markets.businessinsider.comUnited Healthcare data breach may have affected 190 million AmericansJanuary 27, 2025 | msn.comUnitedHealth CEO: American healthcare needs to be "less complex and less confusing'January 17, 2025 | msn.comUnitedHealth tops profit forecasts but medical costs linger for health care giantJanuary 16, 2025 | msn.comNews Wrap: United Healthcare CEO killed in brazen and targeted attack, New York police sayDecember 5, 2024 | pbs.orgHH Health System, United Healthcare reach agreementNovember 14, 2024 | elkvalleytimes.comUnited Healthcare reaches deal with Huntsville Hospital Health SystemNovember 14, 2024 | decaturdaily.comHow will a Trump presidency reshape US public health? A look at his plans.November 13, 2024 | usatoday.comDreamers eligible for health insurance through Covered California for first time this yearNovember 8, 2024 | thecalifornian.comDuke Health, UnitedHealthcare reach multi-year agreement, impacts over 172K patientsNovember 3, 2024 | msn.comAs ACA sign ups start, more Americans have health insurance than ever. Will it last?November 2, 2024 | msn.comUSA Health sets gala to celebrate health care workers’ impact on patientsOctober 31, 2024 | msn.comUnitedHealth Confirms Change Healthcare Data Breach Impacted 100 Million AmericansOctober 29, 2024 | cpomagazine.comMore than 100 million Americans had their health data exposed in a UnitedHealth hackOctober 26, 2024 | 9to5mac.comCyberattack at UnitedHealth subsidiary Change Healthcare affected 100M AmericansOctober 24, 2024 | startribune.comMore than 1,500 physicians call on Trump to release health care planOctober 18, 2024 | msn.comNew center aims to enhance public health preparedness in Utah and beyondOctober 11, 2024 | msn.comThe Plastic-Free Movement: Redefining Healthcare Disinfection for a Healthier PlanetOctober 9, 2024 | beckershospitalreview.comHealth Care Is on the Ballot AgainOctober 4, 2024 | theatlantic.comNew United Against the Flu toolkit urges vaccination before peak respiratory virus seasonSeptember 28, 2024 | aha.orgMedia Sentiment Over TimeHCYTD, RSLSD, UAHC, and AVGR Company DescriptionsAvinger NASDAQ:AVGR$0.47 0.00 (0.00%) As of 06/20/2025Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.H-CYTE OTCMKTS:HCYTD$2.02 -1.98 (-49.50%) As of 07/11/2022H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.United American Healthcare OTCMKTS:UAHC$0.01 0.00 (-1.45%) As of 06/20/2025 09:52 AM EasternUnited American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
